Crestone enrolls first patient for colon infection drug clinical trial,

Crestone Inc. has enrolled its first patient for phase 2 of a clinical trial for CRS3123, a drug candidate to treat a type of colon infection called a clostridioides difficile infection, or CDI., Crestone Inc. has enrolled its first patient for phase 2 of a clinical trial for CRS3123, a drug candidate to treat a type of colon infection called a clostridioides difficile infection, or CDI., Read More

Scroll to Top